Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
66,52 USD | +0,79% | +1,67% | +20,64% |
Métier
Nombre d'employés: 642
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Generics, Established Brands, and Other
77,0
%
| 275 | 86,8 % | 375 | 77,0 % | +36,40% |
Rare Disease
23,0
%
| 42 | 13,2 % | 112 | 23,0 % | +168,95% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
99,9
%
| 312 | 98,7 % | 486 | 99,9 % | +55,64% |
Canada
0,1
%
| 4 | 1,3 % | 1 | 0,1 % | -85,73% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08/09/20 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 06/05/16 |
Patrick Walsh
CHM | Chairman | 63 | 17/05/18 |
Elizabeth Powell
CMP | Compliance Officer | - | 24/02/22 |
Mary Pao
CTO | Chief Tech/Sci/R&D Officer | - | 24/02/22 |
Chief Tech/Sci/R&D Officer | 56 | 19/11/21 | |
James Marken
COO | Chief Operating Officer | 61 | 01/03/07 |
Krista Davis
HRO | Human Resources Officer | 51 | 12/09/22 |
Meredith Cook
LAW | General Counsel | 50 | 18/07/22 |
Ori Gutwerg
PRN | Corporate Officer/Principal | 50 | 01/02/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 01/05/18 |
Antonio Pera
BRD | Director/Board Member | 66 | 06/08/20 |
David Nash
BRD | Director/Board Member | 68 | 01/10/18 |
Patrick Walsh
CHM | Chairman | 63 | 17/05/18 |
Renee Tannenbaum
BRD | Director/Board Member | 72 | 22/03/22 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 06/08/20 |
Chief Tech/Sci/R&D Officer | 56 | 19/11/21 | |
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 08/09/20 |
Matthew Leonard
BRD | Director/Board Member | 58 | 21/08/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 10 864 | 0 | 0 | 80,64 % |
Action B | 1 | 21 332 065 | 17 211 113 ( 80,68 %) | 263 943 ( 1,237 %) | |
Action C | 0 | 25 000 | 0 | 0 |
Coordonnées société
ANI Pharmaceuticals, Inc.
210 Main Street West
56623, Baudette
+218 634 3500
http://www.anipharmaceuticals.comSecteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+20,64% | 1,38 Md | |
+33,25% | 704 Md | |
+28,59% | 577 Md | |
-3,55% | 348 Md | |
+18,16% | 327 Md | |
+4,36% | 288 Md | |
+14,81% | 234 Md | |
+4,93% | 198 Md | |
-9,78% | 194 Md | |
-3,69% | 147 Md |
- Bourse
- Actions
- Action ANIP
- Société ANI Pharmaceuticals, Inc.